- Nachrichtendetail
-
12.07.2024 14:33:04 - dpa-AFX: *ABBVIE SEEKS FDA AND EMA APPROVAL FOR UPADACITINIB IN GIANT CELL ARTERITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 176,980 | 23.08.24 09:04:19 | +0,500 | +0,28% | 176,220 | 177,120 | 176,980 | 176,480 |
